Pseudoephedrine and Ephedrine to move behind the c

Effective April 10th, 2006, single-entity products containing either pseudoephedrine or ephedrine will be moved from Schedule III to Schedule II on the list of drugs for sale in Ontario. The end result is that these products will have to be asked for at a pharmacy behind the counter. This change is implemented to address the problem of clandestine production of methamphetamine. By placing these products behind-the-counter, it makes difficult for producers of crystal meth to access the precursor ingredients required to make it.